Ventyx Biosciences, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Ventyx Biosciences, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Ventyx Biosciences, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $9.92M, a 16.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $9.92M -$1.93M -16.3% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $10.2M +$8.83M +663% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $10.4M +$8.98M +625% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $11.5M +$9.97M +649% Dec 31, 2023 10-Q 2024-11-07
Q3 2023 $11.8M +$10.2M +627% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.33M -$402K -23.2% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $1.44M +$124K +9.45% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $1.54M +$137K +9.79% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $1.63M Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $1.73M Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $1.31M Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $1.4M Jan 1, 2022 10-K 2023-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.